Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus

Author:

Chang Pengxiang1,Lukosaityte Deimante1,Sealy Joshua E.1,Rijal Pramila23,Sadeyen Jean-Remy1,Bhat Sushant1ORCID,Crossley Sylvia1,Daines Rebecca1,Huang Kuan-Yin A.45,Townsend Alain R.23,Iqbal Munir1ORCID

Affiliation:

1. The Pirbright Institute, Pirbright, Woking, United Kingdom

2. Center for Translational Immunology, Chinese Academy of Medical Science Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

3. MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

4. Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan

5. Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan

Abstract

Avian influenza virus (AIV) H7N9 continues to circulate and evolve in birds, posing a credible threat to humans. Antiviral drugs have proven useful for the treatment of severe influenza infections in humans; however, concerns have been raised as antiviral-resistant mutants have emerged.

Funder

UKRI | Biotechnology and Biological Sciences Research Council

British Council

Royal Society

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3